4SC AG BAIIA
Quel est le BAIIA de 4SC AG?
Le BAIIA de 4SC AG est -€19.42
Quelle est la définition de BAIIA?
Le BAIIA est le bénéfice avant intérêts, impôts, dépréciations et amortissements d’une entreprise. Il s’agit d’une mesure comptable calculée à partir du bénéfice net avant de sustraire les intérêts, impôts et amortissements d’une entreprise, comme mesure de la rentabilité opérationnelle courante de l’entreprise.
Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.
BAIIA des entreprises dans Health Care secteur sur XETRA par rapport à 4SC AG
Que fait 4SC AG?
4SC AG, a clinical-stage biopharmaceutical company, engages in developing small-molecule drugs that target key indications in cancer with high unmet medical needs. The company's products in clinical development stage include Resminostat, an orally administered histone deacetylase inhibitor that is in Phase II clinical trial for the treatment of cutaneous T-cell lymphoma; and Domatinostat, an orally administered small molecule, which is in Phase Ib/II clinical trial for the treatment of melanoma and Phase II clinical trial for the treatment of gastrointestinal tumor. 4SC AG also out-licenses its products to pharma and biotech companies for the treatment of cancer. The company has a collaboration agreement with the Netherlands Cancer Institute to evaluate Domatinostat in the neoadjuvant setting in melanoma. 4SC AG was founded in 1997 and is headquartered in Planegg, Germany.
Entreprises avec baiia similaire à 4SC AG
- BrainChip Ltd a BAIIA de -$19.48
- Seabridge Gold a BAIIA de -CAD$19.45
- The Flowr a BAIIA de -CAD$19.45
- Century Legend () a BAIIA de -HKD$19.44
- Rubicon Minerals a BAIIA de -CAD$19.43
- Rubicon Minerals a BAIIA de -CAD$19.43
- 4SC AG a BAIIA de -€19.42
- Venus Concept a BAIIA de -$19.40
- Navios Maritime a BAIIA de -$19.40
- Aqua Bio Technology ASA a BAIIA de -kr19.39
- Northfield Capital a BAIIA de -CAD$19.36
- Dore Copper Mining a BAIIA de -CAD$19.36
- Dore Copper Mining a BAIIA de -CAD$19.36